[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study]

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Abstract Text:

V Bredow,W Straube,

Prostaglandin E2 is often used for induction of labour. A procedure appropriate for obstetrical condition of the cervix uteri is recommended. 1,472 births with a medical indication were induced in a multicenter-study. With a bishopscore < 5 prostaglandin E2 gel intracervical and with a score between 5 and 8 vaginal tablets were used for induction. Appropriate for the condition of cervix it was allowed to continue the induction. With a bishopscore > 8 an infusion of oxytocin was given. The fetal outcome was evaluated appropriate for the condition of cervix before and during induction of labour. The APGAR-score one minute post partum was < 8 in 10.8 per cent of all neonates. This part was near the same in the gel- and in the tablet group (p > 5%). By continuation of induction, the part with pathological findings was at all times not in relation to the different groups of cervical condition. It's the same by APGAR-scores 5 and 10 minutes after delivery. The acidotic morbidity at all was 10.7%. Also in this connection it was only an unimportant (p > 5%) increasing to observe then the induction was continued. There is no relation between the different groups of cervical condition and the acidotic morbidity. Under observation of mother and child the to cervical condition appropriated used method of induction of labour does not expect a bad neonatal outcome. The longer the cervix is unripen, the higher is the rate of delivery by caesarean section. The exploitation of the possibilities of induction by drugs can be recommended.

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Publishing Authors By Initials

V Bredow,W Straube,

For similar female urogenital diseases and pregnancy complications: pregnancy complications: pregnancy, prolonged research abstracts see: female urogenital diseases and pregnancy complications: pregnancy complications: pregnancy, prolonged research

PUBMED ID PMID:

MEDLINE DATE:

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: Zentralblatt für Gynäkologie

VOLUME: 115

Page Numbers: 530-6

Journal Abbreviation: Zentralbl Gynakol

ISSN: 0044-4197

DAY: 11

MONTH: 02

YEAR: 1993

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 21820100

[Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Keywords Mesh Terms:

KEYWORDS: Pregnancy, Prolonged

MESH TERMS: administration & dosage

Chemical & Substance for Abstract: [Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study] Information

Substance Name: Oxytocin

Registry Number: 50-56-6

Grant and Affiliation Information for [Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status. Results of a multicenter study]

AFFILIATION: Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Medizinischen Fakultät, Ernst-Moritz-Arndt-Universität Greifswald.

Country: GERMANY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zentralbl Gynakol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Fetal outcome after cervical ripeness-adjusted labor induction with prostaglandin E2 in relation to cervix status Results of a multicenter study Related Publications

• A concentric-ring equivalent phased array method to model fields of large axisymmetric ultrasound transducers.
• Barry Straube on the CMS Office of Clinical Standards and Quality. Interview by Pamela K Scarrow.
• Botulinum toxin type-A therapy in cluster headache: an open study.
• Chlamydia pneumoniae infection of aortic smooth muscle cells reduces platelet-derived growth factor receptor-beta expression.
• Commentary. The imperatives for change in the US health care payment and delivery systems are clear.
• Decreased sTNF-RI in migraine patients?
• FES cycling reduces spastic muscle tone in a patient with multiple sclerosis.
• Motor cortex excitability in patients with migraine with aura and hemiplegic migraine.
• Partial improvement of headache in a patient with spontaneous cervical cerebrospinal fluid (CSF) leakage after lumbar blood patch.
• Recognition and evaluation of emotional prosody in individuals with generalized social phobia: a pilot study.
• Reversible dementia and corresponding CSF alterations due to intraspinal lumbosacral metastasis of a prostate carcinoma.
• T-cell subsets and expression of integrins in peripheral blood of patients with migraine.
• Treatment of cluster headache with topiramate: effects and side-effects in five patients.
• Velocity scaling of cue-induced smooth pursuit acceleration obeys constraints of natural motion.
• [Demonstration of immunoglobulins, glycoproteins and beta 2 microglobulin in ovarian cysts and cystic ovarian tumors]
• [Detection of pregnancy-specific beta 1-glycoprotein (SP1), of proteins of the "pregnancy zone" (PZ), of pregnancy-associated plasma protein A (PAPP-A) with 24-hour radial immunodiffusion. Detection of pregnancy-specific beta 1-glycoprotein (SP1) with tur
• [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation]
• [Detection of secretory IgA in urine of patients with urinary tract infection in pregnancy and puerperium (author's transl)]
• [Detection of secretory immunoglobulin A in cervical secretion and in cervicovaginal irrigation fluids]
• [Detection of secretory immunoglobulin A in vaginal fluid of hysterectomised women]
• [Estimation of secretory immunoglobulin A in serum of pregnant women (author's transl)]
• [Immunoglobulin M and alpha 2-macroglobulin in the amniotic fluid in neural tube defects]
• [Maternal serum IgA in intrauterine fetal growth retardation]
• [Mission oriented diagnostic real-time PCR.]
• [Not Available.]
• [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy]
• [Relation of AFP and glucose in amniotic fluid]
• [Secretory immunoglobulin A (S-IgA) in amniotic fluid and in pharyngeal mucus and urine of newborn infants]
• [Secretory immunoglobulin A (S-IgA)/immunoglobulin A (IgA) ratio in cervico-vaginal lavage fluids]
• [Serum concentration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG, protein of pregnancy zone, PZ) in patients with dermatological diseases (author's transl)]